Table 1.
Definition of hypertension | |||
---|---|---|---|
2017 ACC/AHA | JNC7 | JNC8a | |
General population | |||
SBP | ≥130 | ≥140 | ≥140 |
DBP | ≥80 | ≥90 | ≥90 |
Recommended anti-hypertensive medication | |||
General population | |||
SBP | ≥140 | ≥140 | ≥140 |
DBP | ≥90 | ≥90 | ≥90 |
Diabetes or CKD | |||
SBP | ≥130 | ≥130 | ≥140 |
DBP | ≥80 | ≥80 | ≥90 |
High cardiovascular disease risk | |||
SBP | ≥130 | — | — |
DBP | ≥80 | — | — |
Age ≥65 years | |||
SBP | ≥130 | — | — |
DBP | ≥80 | — | — |
Age ≥60 years without diabetes or CKD | |||
SBP | — | — | ≥150 |
DBP | — | — | ≥90 |
Treatment goal among those on anti-hypertensive medication b | |||
General population | |||
SBP | <130 | <140 | <140 |
DBP | <80 | <90 | <90 |
Diabetes or CKD | |||
SBP | <130 | <130 | <140 |
DBP | <80 | <80 | <90 |
High cardiovascular disease riskc | |||
SBP | <130 | — | — |
DBP | <80 | — | — |
Age ≥65 years | |||
SBP | <130 | — | — |
DBP | <80 | — | — |
Age ≥60 years without diabetes or CKD | |||
SBP | — | — | <150 |
DBP | — | — | <90 |
- The same approach as other thresholds should be applied.
aDefinitions of hypertension and prehypertension not addressed in JNC8; the same approach as JNC7 should be applied.
bTo achieve treatment goal, both SBP and DBP goals have to be met.
cHigh cardiovascular disease risk is defined as 10-year predicted cardiovascular risk ≥10% using pooled cohort risk equation or prevalent of CVD.
2017ACC/AHA guideline: 2017 American College of Cardiology/American Heart Association Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
JNC7 guideline: The Seventh Report. Of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
JNC8 guideline: Panel member report- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults.
SBP: systolic blood pressure; DBP: diastolic blood pressure; CKD: chronic kidney disease;